About Panadol
Panadol is one of the UK's most trusted paracetamol brands, first introduced to British hospitals in 1955 before becoming commercially available in 1956. Originally prescription-only, Panadol established itself with the promise of being gentle on the stomach, offering pain relief without the gastric irritation associated with aspirin-based alternatives. The brand has passed through several corporate owners during its 70-year history. Originally produced by Sterling Drug Inc., Panadol eventually became part of SmithKline Beecham, then GlaxoSmithKline (GSK). In July 2022, Panadol became part of Haleon, the consumer healthcare company that spun off from GSK in a £30 billion demerger. Haleon, headquartered in Weybridge, England, also owns Sensodyne and Voltaren. Panadol's active ingredient is paracetamol, one of the world's most widely used analgesics first synthesized in 1878. While chemically identical to generic paracetamol, Panadol offers specific formulations for different needs. Panadol Extra combines paracetamol with caffeine for enhanced effectiveness, Panadol Night includes a sleep aid, and children's Panadol provides age-appropriate dosing for young patients. Today, Panadol is marketed in 85 countries worldwide, testament to the trust the brand has built over seven decades. From headaches and fevers to muscle aches and cold symptoms, Panadol remains a medicine cabinet essential for millions of families seeking gentle, effective pain relief.






